Skip to main content
. 2019 Aug 30;7(3):66. doi: 10.3390/biomedicines7030066

Table 5.

Types of cancer with reported sensitivity to NDV virotherapy.

Melanoma (6, 88, 108, 132, 133)
Breast carcinoma (51, 63, 69, 101, 138, 163)
Ovarian carcinoma (119, 160, 164)
Colorectal carcinoma (67, 113, 139, 142, 143, 157)
Head and Neck squamous cell carcinoma (141)
Gastrointestinal carcinoma (144)
Pancreatic carcinoma (41, 44, 45, 46)
Renal cell carcinoma (109, 134)
Prostate carcinoma (162, 174)
Lung carcinoma (104, 105, 229)
Hepatocellular carcinoma (175, 183, 184)
Glioblastoma multiforme (65, 70, 106, 140, 145, 147, 164, 191)
Lymphoma (84, 86, 87, 135, 136, 193, 194, 195, 226)